4.3 Article

Platelet Activation in Alzheimer's Disease: From Pathophysiology to Clinical Value

期刊

CURRENT VASCULAR PHARMACOLOGY
卷 10, 期 5, 页码 626-630

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/157016112801784657

关键词

Alzheimer's disease; platelet activation; treatment targets; vascular risk factors

资金

  1. Hirnliga e.V.

向作者/读者索取更多资源

Vascular risk factors and atherosclerosis are critically involved in dementia development of both vascular and Alzheimer's type. However, the exact mechanisms linking atherosclerosis and the development of Alzheimer's disease ( AD) are still unknown. As platelet activation and adhesion on vascular wall is the first step of vascular inflammation and atherosclerosis, it appears tempting to hypothesize that platelets could be the link between vascular risk factors/atherosclerosis and AD. In recent years, much work has been accomplished to elucidate the role of platelets in AD. The present review will summarize and highlight the latest findings of this research area and provide novel insight and understanding in the association between platelet activation and AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Cardiac & Cardiovascular Systems

DTherapeutic potential of adenosine kinase inhibition in vascular disease

Simon Tual-Chalot, Konstantinos Stellos

CARDIOVASCULAR RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system

Luca Liberale, Alexander Akhmedov, Nikolaos Vlachogiannis, Nicole R. Bonetti, Vanasa Nageswaran, Melroy X. Miranda, Yustina M. Puspitasari, Lena Schwarz, Sarah Costantino, Francesco Paneni, Jurg H. Beer, Frank Ruschitzka, Fabrizio Montecucco, Thomas F. Luscher, Kimon Stamatelopoulos, Konstantinos Stellos, Giovanni G. Camici

Summary: This study demonstrates the important role of SIRT5 in arterial thrombus formation by modulating the activation of the fibrinolysis system through regulating the expression of PAI-1 in endothelial cells. Therefore, SIRT5 may be an interesting therapeutic target in the context of atherothrombotic events.

CARDIOVASCULAR RESEARCH (2021)

Article Rheumatology

Clinical value of amyloid-beta1-40 as a marker of thrombo-inflammation in antiphospholipid syndrome

Maria G. Tektonidou, Evrydiki Kravvariti, Nikolaos Vlachogiannis, Georgios Georgiopoulos, Aimilia Mantzou, Petros P. Sfikakis, Konstantinos Stellos, Kimon Stamatelopoulos

Summary: In patients with Antiphospholipid Syndrome (APS), elevated plasma levels of Aβ40 are associated with adverse thrombo-inflammatory profile, and independently correlated with recurrent arterial events. Aβ40 levels provide additional value in improving the discrimination ability for recurrent arterial thromboses over the validated risk score aGAPSS in APS.

RHEUMATOLOGY (2021)

Editorial Material Cardiac & Cardiovascular Systems

Scientists on the Spot: RNA modifications in atherosclerosis

Monika Gladka, Konstantinos Stellos

CARDIOVASCULAR RESEARCH (2021)

Article Hematology

Circulating Amyloid Beta 1-40 Is Associated with Increased Rate of Progression of Atherosclerosis in Menopause: A Prospective Cohort Study

Irene Lambrinoudaki, Dimitrios Delialis, Georgios Georgiopoulos, Simon Tual-Chalot, Nikolaos I. Vlachogiannis, Raphael Patras, Evmorfia Aivalioti, Eleni Armeni, Areti Augoulea, Nikolaos Tsoltos, Anastasia Soureti, Konstantinos Stellos, Kimon Stamatelopoulos

Summary: Elevated levels of Alpha beta 1-40 may be associated with the progression of atherosclerosis in postmenopausal women. Patterns of persistently high or increasing Alpha beta 1-40 levels could be linked to accelerated subclinical atherosclerosis progression.

THROMBOSIS AND HAEMOSTASIS (2021)

Article Oncology

Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study

Efstathios Kastritis, Ageliki Laina, Georgios Georgiopoulos, Maria Gavriatopoulou, Eleni-Dimitra Papanagnou, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Nikolaos Kanellias, Ioanna Dialoupi, Nikolaos Makris, Efstathios Manios, Magdalini Migkou, Maria Roussou, Maria Kotsopoulou, Konstantinos Stellos, Evangelos Terpos, Ioannis P. Trougakos, Kimon Stamatelopoulos, Meletios A. Dimopoulos

Summary: Carfilzomib treatment for relapsed/refractory multiple myeloma impairs endothelial function and is associated with cardiovascular adverse events. Lower baseline FMD and a significant decrease in FMD during the first treatment cycle may predict the occurrence of CVAEs.

LEUKEMIA (2021)

Article Cardiac & Cardiovascular Systems

Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis

Aikaterini Gatsiou, Georgios Georgiopoulos, Nikolaos I. Vlachogiannis, Larissa Pfisterer, Ariane Fischer, Marco Sachse, Ageliki Laina, Francesca Bonini, Dimitrios Delialis, Simon Tual-Chalot, Eleftherios Zormpas, Rawlings Achangwa, Longchang Jiang, Christos Kontogiannis, Raphael Patras, Heiko Hermeking, Andreas M. Zeiher, Kimon Stamatelopoulos, Stefanie Dimmeler, Konstantinos Stellos

Summary: The study revealed that miR-34a and miR-34c are associated with coronary artery disease and atherosclerosis in humans, highlighting the clinical significance of miR-34a/b/c in vascular aging and atherosclerotic vascular disease. The mechanistic findings showed that miR-34a and miR-34c control SIRT1 and JAG1, respectively, indicating a role in disease pathogenesis.

ATHEROSCLEROSIS (2021)

Review Immunology

The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection

Nikolaos Vlachogiannis, Kleio-Maria Verrou, Konstantinos Stellos, Petros P. Sfikakis, Dimitrios Paraskevis

Summary: RNA editing, specifically A-to-I and C-to-U deamination, can have significant effects on RNA viruses and host immune responses. Evidence suggests potential RNA editing in the SARS-CoV-2 genome, with implications for viral replication and immune response modulation. Further studies are needed to explore the impact of RNA editing on SARS-CoV-2.

CLINICAL IMMUNOLOGY (2021)

Article Immunology

The Fractalkine Receptor CX3CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling

Luke Spray, Catherine Park, Suzanne Cormack, Ashfaq Mohammed, Pedram Panahi, Stephen Boag, Karim Bennaceur, Kateryna Sopova, Gavin Richardson, Verena M. Stangl, Lavinia Rech, Peter P. Rainer, Gustavo Campos Ramos, Ulrich Hofmann, Konstantinos Stellos, Ioakim Spyridopoulos

Summary: Latent CMV infection is associated with poor cardiovascular outcomes, with CMV+ patients showing more adverse LV remodeling possibly due to loss of CX(3)CR1(+) T-cells.

FRONTIERS IN IMMUNOLOGY (2021)

Article Ophthalmology

Human Platelets Take up Anti-VEGF Agents

B. Sobolewska, B. Fehrenbacher, P. Muenzer, H. Kalbacher, S. Geue, Konstantinos Stellos, M. Schaller, F. Ziemssen

Summary: This study found that all three anti-VEGF agents (ranibizumab, aflibercept, and bevacizumab) can be taken up by platelets and localized in different compartments. The co-localization with VEGF may lead to higher local exposure after platelet activation. Additionally, clathrin-coated vesicles seem to play a more prominent role in the transport of bevacizumab compared to the other two agents.

JOURNAL OF OPHTHALMOLOGY (2021)

Article Cell Biology

Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State

Aikaterini Gatsiou, Kateryna Sopova, Alexandros Tselepis, Konstantinos Stellos

Summary: Platelets are immune cells known for their haemostatic properties and play a key role in vascular regeneration and angiogenesis by releasing growth factors. The IL-17A/IL-17RA axis selectively induces the release of pro-angiogenic factors from platelets, affecting endothelial cells and driving them towards a pro-angiogenic state.
Article Immunology

Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis

Nikolaos Vlachogiannis, Simon Tual-Chalot, Eleftherios Zormpas, Francesca Bonini, Panagiotis A. Ntouros, Maria Pappa, Vasiliki-Kalliopi Bournia, Maria G. Tektonidou, Vassilis L. Souliotis, Clio P. Mavragani, Kimon Stamatelopoulos, Aikaterini Gatsiou, Petros P. Sfikakis, Konstantinos Stellos

Summary: This study demonstrates that ADAR1p150-mediated A-to-I RNA editing is critically involved in type I IFN responses in systemic sclerosis patients, highlighting the importance of post-transcriptional regulation in proinflammatory gene expression in autoimmune diseases such as SSc.

JOURNAL OF AUTOIMMUNITY (2021)

Article Cardiac & Cardiovascular Systems

Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease

Nikolaos I. Vlachogiannis, Marco Sachse, Georgios Georgiopoulos, Eleftherios Zormpas, Dimitrios Bampatsias, Dimitrios Delialis, Francesca Bonini, George Galyfos, Fragiska Sigala, Kimon Stamatelopoulos, Aikaterini Gatsiou, Konstantinos Stellos

Summary: NEAT1 lncRNA expression is increased in atherosclerosis-related diseases, and may be controlled through ADAR1-catalyzed A-to-I RNA editing to regulate its stability.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)

Article Multidisciplinary Sciences

Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19

Kimon Stamatelopoulos, Georgios Georgiopoulos, Kenneth F. Baker, Giusy Tiseo, Dimitrios Delialis, Charalampos Lazaridis, Greta Barbieri, Stefano Masi, Nikolaos Vlachogiannis, Kateryna Sopova, Alessandro Mengozzi, Lorenzo Ghiadoni, Ina Schim van der Loeff, Aidan T. Hanrath, Bajram Ajdini, Charalambos Vlachopoulos, Meletios A. Dimopoulos, Christopher J. A. Duncan, Marco Falcone, Konstantinos Stellos

Summary: Accurate risk stratification is crucial in guiding therapeutic strategies for COVID-19 patients. This study found that estimated pulse wave velocity (ePWV), a marker of arterial stiffness, provided additional prognostic value beyond established risk factors and scores in risk stratification of hospitalized COVID-19 patients. The optimal prognostic ePWV value was 13.0 m/s, suggesting its potential as a clinical tool for refining risk stratification in these patients.

SCIENTIFIC REPORTS (2021)

Article Cardiac & Cardiovascular Systems

Circulating and Myocardial Cytokines Predict Cardiac Structural and Functional Improvement in Patients With Heart Failure Undergoing Mechanical Circulatory Support

Nikolaos A. Diakos, Iosif Taleb, Christos P. Kyriakopoulos, Kevin S. Shah, Hadi Javan, Tyler J. Richins, Michael Y. Yin, Chi-Gang Yen, Elizabeth Dranow, Michael J. Bonios, Rami Alharethi, Antigone G. Koliopoulou, Mariam Taleb, James C. Fang, Craig H. Selzman, Konstantinos Stellos, Stavros G. Drakos

Summary: In patients with advanced heart failure, baseline myocardial and systemic inflammatory burden inversely correlates with cardiac improvement following LVAD support. Results indicate that low levels of specific cytokines can independently predict cardiac improvement post LVAD support based on inflammatory marker measurements.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

暂无数据